0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Clinical Trials Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-4T3362
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Clinical Trials Imaging Market Insights and Forecast to 2028
BUY CHAPTERS

Clinical Trials Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-4T3362
Report
October 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Trials Imaging - Market Size

The global market for Clinical Trials Imaging was estimated to be worth US$ 1379.4 million in 2023 and is forecast to a readjusted size of US$ 2281.9 million by 2030 with a CAGR of 7.3% during the forecast period 2024-2030

Clinical Trials Imaging - Market

Clinical Trials Imaging - Market

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Clinical Trials Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trials Imaging by region & country, by Type, and by Application.
The Clinical Trials Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials Imaging.
Market Segmentation

Scope of Clinical Trials Imaging - Market Report

Report Metric Details
Report Name Clinical Trials Imaging - Market
Forecasted market size in 2030 US$ 2281.9 million
CAGR 7.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Computed Tomography
  • Ultrasound
  • Echocardiography
  • Magnetic Resonance Imaging
  • Positron Emission Tomography
  • X-Ray
  • Other Modalities
Segment by Application
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Medical Device Manufacturers
  • Academic and Government Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies, Intrinsic Imaging, Worldcare Clinical, Virtualscopics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Clinical Trials Imaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Clinical Trials Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Clinical Trials Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Clinical Trials Imaging - Market size in 2030?

Ans: The Clinical Trials Imaging - Market size in 2030 will be US$ 2281.9 million.

What is the market share of major companies in Clinical Trials Imaging - Market?

Ans: The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%.

Who are the main players in the Clinical Trials Imaging - Market report?

Ans: The main players in the Clinical Trials Imaging - Market are Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies, Intrinsic Imaging, Worldcare Clinical, Virtualscopics

What are the Application segmentation covered in the Clinical Trials Imaging - Market report?

Ans: The Applications covered in the Clinical Trials Imaging - Market report are Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Medical Device Manufacturers, Academic and Government Research Institutes, Others

What are the Type segmentation covered in the Clinical Trials Imaging - Market report?

Ans: The Types covered in the Clinical Trials Imaging - Market report are Computed Tomography, Ultrasound, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, X-Ray, Other Modalities

1 Market Overview
1.1 Clinical Trials Imaging Product Introduction
1.2 Global Clinical Trials Imaging Market Size Forecast
1.3 Clinical Trials Imaging Market Trends & Drivers
1.3.1 Clinical Trials Imaging Industry Trends
1.3.2 Clinical Trials Imaging Market Drivers & Opportunity
1.3.3 Clinical Trials Imaging Market Challenges
1.3.4 Clinical Trials Imaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clinical Trials Imaging Players Revenue Ranking (2023)
2.2 Global Clinical Trials Imaging Revenue by Company (2019-2024)
2.3 Key Companies Clinical Trials Imaging Manufacturing Base Distribution and Headquarters
2.4 Key Companies Clinical Trials Imaging Product Offered
2.5 Key Companies Time to Begin Mass Production of Clinical Trials Imaging
2.6 Clinical Trials Imaging Market Competitive Analysis
2.6.1 Clinical Trials Imaging Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Clinical Trials Imaging Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials Imaging as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Computed Tomography
3.1.2 Ultrasound
3.1.3 Echocardiography
3.1.4 Magnetic Resonance Imaging
3.1.5 Positron Emission Tomography
3.1.6 X-Ray
3.1.7 Other Modalities
3.2 Global Clinical Trials Imaging Sales Value by Type
3.2.1 Global Clinical Trials Imaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clinical Trials Imaging Sales Value, by Type (2019-2030)
3.2.3 Global Clinical Trials Imaging Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology Companies
4.1.2 Pharmaceutical Companies
4.1.3 Contract Research Organizations
4.1.4 Medical Device Manufacturers
4.1.5 Academic and Government Research Institutes
4.1.6 Others
4.2 Global Clinical Trials Imaging Sales Value by Application
4.2.1 Global Clinical Trials Imaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clinical Trials Imaging Sales Value, by Application (2019-2030)
4.2.3 Global Clinical Trials Imaging Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Clinical Trials Imaging Sales Value by Region
5.1.1 Global Clinical Trials Imaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clinical Trials Imaging Sales Value by Region (2019-2024)
5.1.3 Global Clinical Trials Imaging Sales Value by Region (2025-2030)
5.1.4 Global Clinical Trials Imaging Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Clinical Trials Imaging Sales Value, 2019-2030
5.2.2 North America Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Clinical Trials Imaging Sales Value, 2019-2030
5.3.2 Europe Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Clinical Trials Imaging Sales Value, 2019-2030
5.4.2 Asia Pacific Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Clinical Trials Imaging Sales Value, 2019-2030
5.5.2 South America Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Clinical Trials Imaging Sales Value, 2019-2030
5.6.2 Middle East & Africa Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clinical Trials Imaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clinical Trials Imaging Sales Value
6.3 United States
6.3.1 United States Clinical Trials Imaging Sales Value, 2019-2030
6.3.2 United States Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clinical Trials Imaging Sales Value, 2019-2030
6.4.2 Europe Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clinical Trials Imaging Sales Value, 2019-2030
6.5.2 China Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clinical Trials Imaging Sales Value, 2019-2030
6.6.2 Japan Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clinical Trials Imaging Sales Value, 2019-2030
6.7.2 South Korea Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clinical Trials Imaging Sales Value, 2019-2030
6.8.2 Southeast Asia Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clinical Trials Imaging Sales Value, 2019-2030
6.9.2 India Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clinical Trials Imaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bioclinica
7.1.1 Bioclinica Profile
7.1.2 Bioclinica Main Business
7.1.3 Bioclinica Clinical Trials Imaging Products, Services and Solutions
7.1.4 Bioclinica Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.1.5 Bioclinica Recent Developments
7.2 Parexel International
7.2.1 Parexel International Profile
7.2.2 Parexel International Main Business
7.2.3 Parexel International Clinical Trials Imaging Products, Services and Solutions
7.2.4 Parexel International Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.2.5 Parexel International Recent Developments
7.3 Radiant Sage
7.3.1 Radiant Sage Profile
7.3.2 Radiant Sage Main Business
7.3.3 Radiant Sage Clinical Trials Imaging Products, Services and Solutions
7.3.4 Radiant Sage Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.3.5 Biomedical Systems Recent Developments
7.4 Biomedical Systems
7.4.1 Biomedical Systems Profile
7.4.2 Biomedical Systems Main Business
7.4.3 Biomedical Systems Clinical Trials Imaging Products, Services and Solutions
7.4.4 Biomedical Systems Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.4.5 Biomedical Systems Recent Developments
7.5 Biotelemetry
7.5.1 Biotelemetry Profile
7.5.2 Biotelemetry Main Business
7.5.3 Biotelemetry Clinical Trials Imaging Products, Services and Solutions
7.5.4 Biotelemetry Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.5.5 Biotelemetry Recent Developments
7.6 Icon
7.6.1 Icon Profile
7.6.2 Icon Main Business
7.6.3 Icon Clinical Trials Imaging Products, Services and Solutions
7.6.4 Icon Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.6.5 Icon Recent Developments
7.7 IXICO
7.7.1 IXICO Profile
7.7.2 IXICO Main Business
7.7.3 IXICO Clinical Trials Imaging Products, Services and Solutions
7.7.4 IXICO Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.7.5 IXICO Recent Developments
7.8 Cardiovascular Imaging Technologies
7.8.1 Cardiovascular Imaging Technologies Profile
7.8.2 Cardiovascular Imaging Technologies Main Business
7.8.3 Cardiovascular Imaging Technologies Clinical Trials Imaging Products, Services and Solutions
7.8.4 Cardiovascular Imaging Technologies Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.8.5 Cardiovascular Imaging Technologies Recent Developments
7.9 Intrinsic Imaging
7.9.1 Intrinsic Imaging Profile
7.9.2 Intrinsic Imaging Main Business
7.9.3 Intrinsic Imaging Clinical Trials Imaging Products, Services and Solutions
7.9.4 Intrinsic Imaging Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.9.5 Intrinsic Imaging Recent Developments
7.10 Worldcare Clinical
7.10.1 Worldcare Clinical Profile
7.10.2 Worldcare Clinical Main Business
7.10.3 Worldcare Clinical Clinical Trials Imaging Products, Services and Solutions
7.10.4 Worldcare Clinical Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.10.5 Worldcare Clinical Recent Developments
7.11 Virtualscopics
7.11.1 Virtualscopics Profile
7.11.2 Virtualscopics Main Business
7.11.3 Virtualscopics Clinical Trials Imaging Products, Services and Solutions
7.11.4 Virtualscopics Clinical Trials Imaging Revenue (US$ Million) & (2019-2024)
7.11.5 Virtualscopics Recent Developments
8 Industry Chain Analysis
8.1 Clinical Trials Imaging Industrial Chain
8.2 Clinical Trials Imaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clinical Trials Imaging Sales Model
8.5.2 Sales Channel
8.5.3 Clinical Trials Imaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Clinical Trials Imaging Market Trends
    Table 2. Clinical Trials Imaging Market Drivers & Opportunity
    Table 3. Clinical Trials Imaging Market Challenges
    Table 4. Clinical Trials Imaging Market Restraints
    Table 5. Global Clinical Trials Imaging Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Clinical Trials Imaging Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Clinical Trials Imaging Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Clinical Trials Imaging Product Type
    Table 9. Key Companies Time to Begin Mass Production of Clinical Trials Imaging
    Table 10. Global Clinical Trials Imaging Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials Imaging as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Clinical Trials Imaging Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Clinical Trials Imaging Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Clinical Trials Imaging Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Clinical Trials Imaging Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Clinical Trials Imaging Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Clinical Trials Imaging Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Clinical Trials Imaging Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Clinical Trials Imaging Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Clinical Trials Imaging Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Clinical Trials Imaging Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Clinical Trials Imaging Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Clinical Trials Imaging Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Clinical Trials Imaging Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Clinical Trials Imaging Sales Value by Region (2019-2024) & (%)
    Table 27. Global Clinical Trials Imaging Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Clinical Trials Imaging Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Clinical Trials Imaging Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Clinical Trials Imaging Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bioclinica Basic Information List
    Table 32. Bioclinica Description and Business Overview
    Table 33. Bioclinica Clinical Trials Imaging Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Clinical Trials Imaging Business of Bioclinica (2019-2024)
    Table 35. Bioclinica Recent Developments
    Table 36. Parexel International Basic Information List
    Table 37. Parexel International Description and Business Overview
    Table 38. Parexel International Clinical Trials Imaging Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Clinical Trials Imaging Business of Parexel International (2019-2024)
    Table 40. Parexel International Recent Developments
    Table 41. Radiant Sage Basic Information List
    Table 42. Radiant Sage Description and Business Overview
    Table 43. Radiant Sage Clinical Trials Imaging Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Clinical Trials Imaging Business of Radiant Sage (2019-2024)
    Table 45. Radiant Sage Recent Developments
    Table 46. Biomedical Systems Basic Information List
    Table 47. Biomedical Systems Description and Business Overview
    Table 48. Biomedical Systems Clinical Trials Imaging Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Clinical Trials Imaging Business of Biomedical Systems (2019-2024)
    Table 50. Biomedical Systems Recent Developments
    Table 51. Biotelemetry Basic Information List
    Table 52. Biotelemetry Description and Business Overview
    Table 53. Biotelemetry Clinical Trials Imaging Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Clinical Trials Imaging Business of Biotelemetry (2019-2024)
    Table 55. Biotelemetry Recent Developments
    Table 56. Icon Basic Information List
    Table 57. Icon Description and Business Overview
    Table 58. Icon Clinical Trials Imaging Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Clinical Trials Imaging Business of Icon (2019-2024)
    Table 60. Icon Recent Developments
    Table 61. IXICO Basic Information List
    Table 62. IXICO Description and Business Overview
    Table 63. IXICO Clinical Trials Imaging Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Clinical Trials Imaging Business of IXICO (2019-2024)
    Table 65. IXICO Recent Developments
    Table 66. Cardiovascular Imaging Technologies Basic Information List
    Table 67. Cardiovascular Imaging Technologies Description and Business Overview
    Table 68. Cardiovascular Imaging Technologies Clinical Trials Imaging Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Clinical Trials Imaging Business of Cardiovascular Imaging Technologies (2019-2024)
    Table 70. Cardiovascular Imaging Technologies Recent Developments
    Table 71. Intrinsic Imaging Basic Information List
    Table 72. Intrinsic Imaging Description and Business Overview
    Table 73. Intrinsic Imaging Clinical Trials Imaging Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Clinical Trials Imaging Business of Intrinsic Imaging (2019-2024)
    Table 75. Intrinsic Imaging Recent Developments
    Table 76. Worldcare Clinical Basic Information List
    Table 77. Worldcare Clinical Description and Business Overview
    Table 78. Worldcare Clinical Clinical Trials Imaging Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Clinical Trials Imaging Business of Worldcare Clinical (2019-2024)
    Table 80. Worldcare Clinical Recent Developments
    Table 81. Virtualscopics Basic Information List
    Table 82. Virtualscopics Description and Business Overview
    Table 83. Virtualscopics Clinical Trials Imaging Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Clinical Trials Imaging Business of Virtualscopics (2019-2024)
    Table 85. Virtualscopics Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Clinical Trials Imaging Downstream Customers
    Table 89. Clinical Trials Imaging Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Clinical Trials Imaging Product Picture
    Figure 2. Global Clinical Trials Imaging Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Clinical Trials Imaging Sales Value (2019-2030) & (US$ Million)
    Figure 4. Clinical Trials Imaging Report Years Considered
    Figure 5. Global Clinical Trials Imaging Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Clinical Trials Imaging Revenue in 2023
    Figure 7. Clinical Trials Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Computed Tomography Picture
    Figure 9. Ultrasound Picture
    Figure 10. Echocardiography Picture
    Figure 11. Magnetic Resonance Imaging Picture
    Figure 12. Positron Emission Tomography Picture
    Figure 13. X-Ray Picture
    Figure 14. Other Modalities Picture
    Figure 15. Global Clinical Trials Imaging Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Clinical Trials Imaging Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Product Picture of Biotechnology Companies
    Figure 18. Product Picture of Pharmaceutical Companies
    Figure 19. Product Picture of Contract Research Organizations
    Figure 20. Product Picture of Medical Device Manufacturers
    Figure 21. Product Picture of Academic and Government Research Institutes
    Figure 22. Product Picture of Others
    Figure 23. Global Clinical Trials Imaging Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Clinical Trials Imaging Sales Value Market Share by Application, 2023 & 2030
    Figure 25. North America Clinical Trials Imaging Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Clinical Trials Imaging Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Clinical Trials Imaging Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Clinical Trials Imaging Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Clinical Trials Imaging Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Clinical Trials Imaging Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Clinical Trials Imaging Sales Value (%), (2019-2030)
    Figure 36. United States Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 37. United States Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 38. United States Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 39. Europe Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Europe Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 41. Europe Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 42. China Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 43. China Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 44. China Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 45. Japan Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Japan Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 47. Japan Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 48. South Korea Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 49. South Korea Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 50. South Korea Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 51. Southeast Asia Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Southeast Asia Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 53. Southeast Asia Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 54. India Clinical Trials Imaging Sales Value, (2019-2030) & (US$ Million)
    Figure 55. India Clinical Trials Imaging Sales Value by Type (%), 2023 VS 2030
    Figure 56. India Clinical Trials Imaging Sales Value by Application (%), 2023 VS 2030
    Figure 57. Clinical Trials Imaging Industrial Chain
    Figure 58. Clinical Trials Imaging Manufacturing Cost Structure
    Figure 59. Channels of Distribution (Direct Sales, and Distribution)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS